These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3727715)

  • 21. Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.
    Aramendi JL; Agredo J; Llorente A; Larrarte C; Pijoan J
    J Heart Valve Dis; 1998 Nov; 7(6):610-4. PubMed ID: 9870193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of heart valve replacement: especially on the selection criteria for valve prostheses and on a new anticoagulation regimen].
    Sugimura S; Ozawa K; Iriyama T; Hattori Y; Watanabe K; Sai N
    Rinsho Kyobu Geka; 1989 Jun; 9(3):273-9. PubMed ID: 9301929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fifteen years follow up with the St. Jude Medical Biocor porcine bioprosthesis.
    Mykén P; Bech-Hanssen O; Phipps B; Caidahl K
    J Heart Valve Dis; 2000 May; 9(3):415-22. PubMed ID: 10888100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of intravascular hemolysis on the body of rheumatics with heart valve prostheses].
    Orlovskiĭ PI; Davydenko VV; Gritsenko VV; Kriukova GG; Golova EP
    Ter Arkh; 1989; 61(10):15-7. PubMed ID: 2609261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Late complications following heart valve replacement].
    Niederer W
    Fortschr Med; 1984 Nov; 102(42):1077-81. PubMed ID: 6510859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six-and-half years' experience with the St. Jude BioImplant porcine prosthesis.
    Triggiani M; D'Ancona G; Nascimbene S; Benussi S; Donatelli F; Paolini G; Galli L; Grossi A
    J Heart Valve Dis; 1997 Mar; 6(2):138-44. PubMed ID: 9130121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow-induced platelet activation in a St. Jude mechanical heart valve, a trileaflet polymeric heart valve, and a St. Jude tissue valve.
    Yin W; Gallocher S; Pinchuk L; Schoephoerster RT; Jesty J; Bluestein D
    Artif Organs; 2005 Oct; 29(10):826-31. PubMed ID: 16185345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decision-making in the choice of heart valve for replacement in patients aged 60-70 years: twenty-year follow up of the St. Jude Medical aortic valve prosthesis.
    Emery RW; Arom KV; Kshettry VR; Kroshus TJ; Von R; Kersten TE; Lillehei TJ; Nicoloff DM; Erickson CA
    J Heart Valve Dis; 2002 Jan; 11 Suppl 1():S37-44. PubMed ID: 11843519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The valve of choice in elderly patients and its influence on quality of life: a long-term comparative study.
    Kurlansky PA; Williams DB; Traad EA; Carrillo RG; Schor JS; Zucker M; Ebra G
    J Heart Valve Dis; 2006 Mar; 15(2):180-9; discussion 190. PubMed ID: 16607898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results with St. Jude Medical and CarboMedics prosthetic heart valves.
    Chang BC; Lim SH; Kim DK; Seo JY; Cho SY; Shim WH; Chung N; Kim SS; Cho BK
    J Heart Valve Dis; 2001 Mar; 10(2):185-194; discussion195. PubMed ID: 11297205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanical versus biological valve prosthesis in the mitral position: a 10-year follow up of St. Jude Medical and Biocor valves.
    Demirag M; Kirali K; Omeroglu SN; Mansuroglu D; Akinci E; Ipek G; Berki T; Gürbüz A; Isik O; Yakut C
    J Heart Valve Dis; 2001 Jan; 10(1):78-83. PubMed ID: 11206772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The St. Jude Medical bileaflet valve prosthesis. A 5 year experience.
    Chaux A; Czer LS; Matloff JM; DeRobertis MA; Stewart ME; Bateman TM; Kass RM; Lee ME; Gray RJ
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):706-17. PubMed ID: 6492839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aortic valve replacement: technique and outcome with artificial heart valves and allografts].
    Vogt PR; Turina MI
    Ther Umsch; 1998 Dec; 55(12):737-45. PubMed ID: 10025187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation?
    Acar J
    J Heart Valve Dis; 1993 Jul; 2(4):395-7. PubMed ID: 8269141
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical evaluation of the St. Jude Medical heart valve prosthesis. A two-year follow-up of 150 patients.
    Burckhardt D; Hoffmann A; Vogt S; Pfisterer M; Hasse J; Grädel E
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):432-8. PubMed ID: 6471892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J; Nitter-Hauge S
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract]   [Full Text] [Related]  

  • 37. [Beall prosthesis. Its use in the surgical treatment of mitral valve diseases].
    Goudard A; Monties JR; Baille Y; Jausseran JM; Sicard MP; Avierinos C; Henry E
    Nouv Presse Med; 1972 Apr; 1(16):1069-72. PubMed ID: 5035862
    [No Abstract]   [Full Text] [Related]  

  • 38. Managing mechanical valves with reduced anticoagulation.
    Slaughter MS; Jweied E
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1073-85. PubMed ID: 18035923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indication of cavitation in mechanical heart valve patients.
    Andersen TS; Johansen P; Paulsen PK; Nygaard H; Hasenkam JM
    J Heart Valve Dis; 2003 Nov; 12(6):790-6. PubMed ID: 14658822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results of mitral valve replacement: biological xenograft versus mechanical valves.
    Yao H; Miyamoto T; Mukai S; Yamamura M; Tanaka H; Nakagawa T; Ryomoto M; Inai Y; Yoshioka Y; Kaji M
    J Artif Organs; 2003; 6(1):30-6. PubMed ID: 14598122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.